CVRX CVRx Inc

Price (delayed)

$2.72

Market cap

$72.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.97

Enterprise value

$66.9M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 27

CVRx is a commercial-stage medical device company focused on the developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostimâ„¢ is the first medical technology approved by ...

Highlights
CVRx's gross profit has increased by 16% YoY and by 4.5% QoQ
CVRX's revenue is up by 12% year-on-year and by 3.6% since the previous quarter
CVRx's equity has plunged by 66% YoY and by 31% from the previous quarter
The quick ratio has contracted by 37% YoY and by 22% from the previous quarter

Key stats

What are the main financial stats of CVRX

CVRX stock price

How has the CVRx stock price performed over time
Intraday
-5.88%
1 week
-9.93%
1 month
-4.23%
1 year
-63.49%
YTD
-61.69%
QTD
-47.08%

Financial performance

How have CVRx's revenue and profit performed over time
Revenue
$61.19M
Gross profit
$53.18M
Operating income
-$48.64M
Net income
-$51.97M
Gross margin
86.9%
Net margin
-84.9%
CVRx's gross profit has increased by 16% YoY and by 4.5% QoQ
The company's operating margin rose by 15% YoY and by 6% QoQ
CVRX's revenue is up by 12% year-on-year and by 3.6% since the previous quarter
CVRX's net margin is up by 11% year-on-year and by 4.7% since the previous quarter

Price vs fundamentals

How does CVRX's price correlate with its fundamentals

Growth

What is CVRx's growth rate over time

Valuation

What is CVRx stock price valuation
P/E
N/A
P/B
3.62
P/S
1.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.09
The EPS is up by 4.8% year-on-year
CVRx's equity has plunged by 66% YoY and by 31% from the previous quarter
The P/B is 37% lower than the last 4 quarters average of 6.1
The P/S is 85% less than the 5-year quarterly average of 8.6 and 63% less than the last 4 quarters average of 3.4
CVRX's revenue is up by 12% year-on-year and by 3.6% since the previous quarter

Efficiency

How efficient is CVRx business performance
The return on equity has dropped by 92% year-on-year and by 26% since the previous quarter
CVRX's ROA is down by 24% YoY and by 5% QoQ
The return on sales is up by 12% year-on-year and by 5% since the previous quarter
The return on invested capital has increased by 8% year-on-year and by 5% since the previous quarter

Dividends

What is CVRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVRX.

Financial health

How did CVRx financials performed over time
The total assets is 28% more than the total liabilities
The quick ratio has contracted by 37% YoY and by 22% from the previous quarter
CVRx's current ratio has decreased by 33% YoY and by 21% from the previous quarter
CVRX's debt is 196% greater than its equity
CVRx's equity has plunged by 66% YoY and by 31% from the previous quarter
CVRx's debt to equity has increased by 46% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.